Ad is loading...
MROPF
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
STSS
Price
$2.65
Change
-$0.16 (-5.69%)
Updated
Nov 15 closing price
10 days until earnings call
Ad is loading...

MROPF vs STSS

Header iconMROPF vs STSS Comparison
Open Charts MROPF vs STSSBanner chart's image
MICROPORT CARDIOFLOW MEDTECH
Price$0.13
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
Sharps Technology
Price$2.65
Change-$0.16 (-5.69%)
Volume$26.71K
CapitalizationN/A
MROPF vs STSS Comparison Chart
Loading...
STSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MROPF vs. STSS commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MROPF is a Hold and STSS is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MROPF: $0.13 vs. STSS: $2.65)
Brand notoriety: MROPF and STSS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MROPF: 41% vs. STSS: 28%
Market capitalization -- MROPF: $695.4M vs. STSS: $5.41M
MROPF [@Medical Specialties] is valued at $695.4M. STSS’s [@Medical Specialties] market capitalization is $5.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MROPF’s FA Score shows that 1 FA rating(s) are green whileSTSS’s FA Score has 1 green FA rating(s).

  • MROPF’s FA Score: 1 green, 4 red.
  • STSS’s FA Score: 1 green, 4 red.
According to our system of comparison, both MROPF and STSS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STSS’s TA Score shows that 5 TA indicator(s) are bullish.

  • STSS’s TA Score: 5 bullish, 3 bearish.

Price Growth

MROPF (@Medical Specialties) experienced а 0.00% price change this week, while STSS (@Medical Specialties) price change was -5.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

STSS is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MROPF($695M) has a higher market cap than STSS($5.41M). MROPF YTD gains are higher at: -60.818 vs. STSS (-71.038). STSS has higher annual earnings (EBITDA): -9M vs. MROPF (-118.59M). MROPF has more cash in the bank: 2.21B vs. STSS (5.55M). STSS has less debt than MROPF: STSS (906K) vs MROPF (126M). MROPF has higher revenues than STSS: MROPF (201M) vs STSS (0).
MROPFSTSSMROPF / STSS
Capitalization695M5.41M12,854%
EBITDA-118.59M-9M1,318%
Gain YTD-60.818-71.03886%
P/E RatioN/AN/A-
Revenue201M0-
Total Cash2.21B5.55M39,827%
Total Debt126M906K13,907%
TECHNICAL ANALYSIS
Technical Analysis
STSS
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
STSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAMPX15.360.13
+0.85%
GS Energy Infrastructure Fd P
PJECX15.530.06
+0.39%
PGIM US Real Estate C
MFWGX17.76-0.04
-0.22%
MFS Global Total Return R1
CNPIX76.68-1.01
-1.30%
Consumer Staples UltraSector ProFund Inv
PCAQX85.57-1.23
-1.42%
Principal Capital Appreciation R5

MROPF and

Correlation & Price change

A.I.dvisor tells us that MROPF and MEDP have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MROPF and MEDP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MROPF
1D Price
Change %
MROPF100%
N/A
MEDP - MROPF
26%
Poorly correlated
-7.23%
SAFLF - MROPF
21%
Poorly correlated
N/A
STSS - MROPF
9%
Poorly correlated
-5.69%
PRE - MROPF
8%
Poorly correlated
-6.44%
OLYMY - MROPF
4%
Poorly correlated
-1.18%
More

STSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STSS has been loosely correlated with SINT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if STSS jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STSS
1D Price
Change %
STSS100%
-5.69%
SINT - STSS
60%
Loosely correlated
-6.85%
HSDT - STSS
36%
Loosely correlated
-5.87%
POAI - STSS
32%
Poorly correlated
-7.23%
ICAD - STSS
24%
Poorly correlated
-8.12%
CATX - STSS
23%
Poorly correlated
-11.66%
More